HappeningToo topic

Clopidogrel Bisulfate reports

Browse community reports connected to Clopidogrel Bisulfate. These reports can show that other people are describing similar experiences, but they do not prove that Clopidogrel Bisulfate caused a symptom or reaction.

⚕️ Medicine safety note

Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.

38 problems

Abdominal Discomfort while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and abdominal discomfort appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Abdominal Pain Upper while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and abdominal pain upper appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Abdominal Pain while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and abdominal pain appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Anxiety while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and anxiety appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Back Pain while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and back pain appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Chest Discomfort while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and chest discomfort appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Constipation while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and constipation appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Cough while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and cough appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Decreased Appetite while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and decreased appetite appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Dehydration while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and dehydration appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Diarrhea while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and diarrhea appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Dizziness while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and dizziness appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Dyspepsia while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and dyspepsia appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Excessive sweating while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and excessive sweating appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Fatigue while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and fatigue appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Feeling Abnormal while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and feeling abnormal appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Headache while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and headache appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Hypotension while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and hypotension appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Insomnia while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and insomnia appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Itching while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and itching appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Malaise while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and malaise appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Muscle Spasms while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and muscle spasms appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Muscular Weakness while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and muscular weakness appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Myalgia while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and myalgia appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Nausea while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and nausea appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Pain while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and pain appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Peripheral swelling while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and peripheral swelling appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Rash while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and rash appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Shortness of breath while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and shortness of breath appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Skin redness while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and skin redness appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Sleepiness while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and sleepiness appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Tingling or pins and needles while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and tingling or pins and needles appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Tremor while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and tremor appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Vision Blurred while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and vision blurred appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Vomiting while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and vomiting appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Weakness while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and weakness appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Weight Decreased while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and weight decreased appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Weight Increased while using Clopidogrel Bisulfate

FDA FAERS contains adverse-event reports in which Clopidogrel Bisulfate and weight increased appear together. This does not establish that Clopidogrel Bisulfate caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →